Lecture 5 - Dermatology 2 Flashcards
(88 cards)
tell tale sign of psoriasis
erythematous papule and plaques with silver scale
Psoriasis risk factors
Genetic predisposition
Environmental Triggers, infection, stress
Medications
Smoking
Obesity & higher BMI in adults and children
Vitamin D deficiency
exacerbating factors for psoriasis
Drugs = BB< lithium, antimalarial meds, ACEi, NSAIDs
Infections, bacterial and viral
Alcohol abuse
Exacerbating comorbidities for psoriasis
CVD
Malignancy
Diabetes
HTN
Metabolic syndrome
IBD
Patients with psoriasis are at increased risk for…..
CV events
Clinical presentation of plaque psoriasis
symmetrically distributed plaques
*sharply defined margins raised above surrounding normal skin
Tick, silvery scale is usually present
Auspit’z sign
1-10cm in diameter
typically asymptomatic, may have itching
Nail psoriasis
most often noted after onset of disease
involvement of nail Matrix or nail bed
nail pitting
Leukonychia
typically req system therapy or sublingual injections
How is severity of psoriasis assessed?
Based on %% of body surface area
Desired outcomes of psoriasis?
minimize or eliminate signs of psoriasis
Alleviate pruritus if present
Reduce frequency & flare ups
Avoid/minimize ADE
cost effective therapy
approve QOL
Non-pharm psoriasis therapy
Stress reduction
Using moisturizers
Oatmeal baths
sunscreen 30+ SPF
Avoidance of irritants
Avoidance of offending agents
Psoriasis: topical corticosteroid therapy
Mainstay of therapy
Location, age, plaque thickness taken into consideration
usually BID
Lower potency Topical steroid used for….
infants and lesions on the face, intertriginous areas (rub together) and area with thin skin
ex. Hydrocortisone 0.5-2.5% cream
Mid-high potency topical steroid used for….
most areas generally recommended
ex. Betamethasone valerate 0.12% ointment
Ultra-High potency topical steroid use for….
very thick plaques or recalcitrant disease
ex. Clobetasol 0.05% cream
Treatment of choice for mild-mod psoriasis…..
Topical corticosteroids
less ADR, QD-BID
Topical Vit D analogs info
inhibit keratinocyte proliferation and enhancement of keratinocyte differentiation
immunosuppressive properties
comparable to group 3 steroids, but more $$ & irritating
Calcitriol < Calcipotriene irritation
Vitamin D analog Safety
Photosensitivity and inc risk of UV-induced skin tumors
Acute psoriatic eruption of scalp can occur
topical solution and foam are flammable
Safe in peds
Vitamin D analog tolerability
Hypercalcemia is concern w/ higher doses (>100g/week)
can worsen psoriasis, cause skin irritation
Topical Vitamin D analog efficacy
Calcipotriene as effective as TCS but more ADR
Greatest efficacy when combo w/ betamethasone
Vitamin D analog clinical pearls
used in combo w/ TCS
inactivated by UVA, apply after not before exposure
BID application, not more than 30% BSA
Tazarotene info
Retinoid
limited absorption, but irritation is major issue and limits use
irritation is dose dependent
therapeutic benefit can persist up to 12weeks after stopping
Tazarotene safety
Preg X
Photosensitivity
Tazarotene Tolerability
Inc sensitivity to environmental factors
Skin burning, stinging, irritation
Tazarotene efficacy
50% improvement in symptoms at 12 weeks in 50% of treated pts